Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen

Allorecognition is the activation of the adaptive immune system to foreign human leukocyte antigen (HLA) resulting in the generation of alloantibodies. Due to a high polymorphism, foreign HLA is recognized by the immune system following transplant, transfusion, or pregnancy resulting in the formatio...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 7; p. 30
Main Authors Hickey, Michelle J, Valenzuela, Nicole M, Reed, Elaine F
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 04.02.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Allorecognition is the activation of the adaptive immune system to foreign human leukocyte antigen (HLA) resulting in the generation of alloantibodies. Due to a high polymorphism, foreign HLA is recognized by the immune system following transplant, transfusion, or pregnancy resulting in the formation of the germinal center and the generation of long-lived alloantibody-producing memory B cells. Alloantibodies recognize antigenic epitopes displayed by the HLA molecule on the transplanted allograft and contribute to graft damage through multiple mechanisms, including (1) activation of the complement cascade resulting in the formation of the MAC complex and inflammatory anaphylatoxins, (2) transduction of intracellular signals leading to cytoskeletal rearrangement, growth, and proliferation of graft vasculature, and (3) immune cell infiltration into the allograft via FcγR interactions with the FC portion of the antibody. This review focuses on the generation of HLA alloantibody, routes of sensitization, alloantibody specificity, and mechanisms of antibody-mediated graft damage.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Specialty section: This article was submitted to Alloimmunity and Transplantation, a section of the journal Frontiers in Immunology
Edited by: Gilles Benichou, Massachusetts General Hospital, USA
Reviewed by: Nuala Mooney, Centre National de la Recherche Scientifique, France; Emmanuel Zorn, Columbia University Medical Center, USA
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2016.00030